Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
Bredemeier M, Ranza R, Kakehasi AM, Ranzolin A, da Silveira IG, Ribeiro ACM, Titton DC, Hayata ALS, Carvalho HMS, Kahlow BS, Fernandes V, Louzada P Jr, Bértolo MB, Duarte ÂLBP, Macieira JC, Miranda JRS, Pinheiro GRC, Teodoro RB, Pinheiro MM, Valim V, Pereira IA, Sauma MFLC, de Castro GRW, da Rocha LF Jr, Studart SAS, Gazzeta MO, da Silveira LG, Lupo CM, Laurindo IMM. Bredemeier M, et al. J Rheumatol. 2022 Jan;49(1):122. doi: 10.3899/jrheum.201248.C1. J Rheumatol. 2022. PMID: 34974425 No abstract available.
Safety of the Methotrexate-leflunomide Combination in Rheumatoid Arthritis: Results of a Multicentric, Registry-based, Cohort Study (BiobadaBrasil).
Bredemeier M, Ranza R, Kakehasi AM, Ranzolin A, da Silveira IG, Ribeiro ACM, Titton DC, Hayata ALS, Carvalho HMS, Kahlow BS, Fernandes V, Louzada P Jr, Bértolo MB, Duarte ÂLBP, Macieira JC, Miranda JRS, Pinheiro GRC, Teodoro RB, Pinheiro MM, Valim V, Pereira IA, Sauma MFLC, de Castro GRW, da Rocha LF Jr, Studart SAS, Gazzeta MO, da Silveira LG, Lupo CM, Laurindo IMM. Bredemeier M, et al. J Rheumatol. 2021 Oct;48(10):1519-1527. doi: 10.3899/jrheum.201248. Epub 2021 May 1. J Rheumatol. 2021. PMID: 33934077
The effect of antimalarials on the safety and persistence of treatment with biologic agents or Janus kinase inhibitors in rheumatoid arthritis.
Bredemeier M, Duarte ÂL, Pinheiro MM, Kahlow BS, Macieira JC, Ranza R, Miranda JR, Valim V, de Castro GR, Bértolo MB, Sauma MF, Fernandes V, Ribeiro AC, Teodoro RB, Brenol CV, Carvalho HM, Studart SA, Pinheiro GR, da Rocha LF Jr, de Lima HD, Pereira IA, Gazzeta MO, Kakehasi AM, Louzada P Jr, Hayata AL, Lupo CM, da Silveira IG, Kowalski SC, Titton DC, Chakr RM, Ranzolin A, Xavier RM, Laurindo IM. Bredemeier M, et al. Rheumatology (Oxford). 2024 Feb 1;63(2):456-465. doi: 10.1093/rheumatology/kead232. Rheumatology (Oxford). 2024. PMID: 37216912
Treatment with biological therapy is associated with faster recovery and lower frequency of treatment switch among rheumatic patients with Chikungunya fever.
Ranzolin A, Marques CDL, da Rocha Junior LF, Duarte ALBP, de Lima HD, de Almeida Martins LM, de Almeida AR, de Oliveira PSS, de Melo Rêgo MJB, da Rocha Pitta MG, Bredemeier M, Laurindo IMM. Ranzolin A, et al. Among authors: bredemeier m. Adv Rheumatol. 2022 Nov 14;62(1):44. doi: 10.1186/s42358-022-00273-0. Adv Rheumatol. 2022. PMID: 36376923
72 results